Boundless Bio, Inc.

Contributing Author

Recent Articles by Boundless Bio, Inc.

Apr-17	Boundless Bio Presents Preclinical Breast Cancer Data from its Oral Kinesin Degrader Program at 2026 AACR Annual Meeting BOLD GlobeNewswire
Mar-17	Boundless Bio Announces Upcoming Presentation of Oral Kinesin Degrader Program at the American Association for Cancer Research Annual Meeting 2026 BOLD GlobeNewswire
Mar-09	Boundless Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights BOLD GlobeNewswire
Mar-04	Boundless Bio to Participate in the Leerink Global Healthcare Conference BOLD GlobeNewswire
Feb-05	Boundless Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 BOLD GlobeNewswire
Jan-20	Boundless Bio Advances Novel Kinesin Degrader Program BBI-940 and Extends Cash Runway BOLD GlobeNewswire
Nov-24	Boundless Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference BOLD GlobeNewswire
Nov-05	Boundless Bio Reports Third Quarter 2025 Financial Results and Business Highlights BOLD GlobeNewswire
Oct-13	Boundless Bio Announces Upcoming Presentation at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics BOLD GlobeNewswire
Aug-05	Boundless Bio Reports Second Quarter 2025 Financial Results and Business Highlights BOLD GlobeNewswire
Jun-05	Boundless Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference BOLD GlobeNewswire
May-23	Boundless Bio Announces Portfolio Prioritization and Runway Extension BOLD -15.58% BOLD GlobeNewswire
May-09	Boundless Bio Reports First Quarter 2025 Financial Results and Business Highlights BOLD GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)